Skip to content

Fulgent Genetics, Inc. FLGT Interest coverage

Interest coverage at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-28.2×-6.5×
Labcorp Holdings logo
Labcorp HoldingsLH
6.4×+1.4×
NeoGenomics logo
NeoGenomicsNEO
-38.9×-84.6×
Natera, Inc. logo
Natera, Inc.NTRA
-81.9×-157×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-4×-1.6×
GeneDx Holdings logo
GeneDx HoldingsWGS
-147.7×+0.3×

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s interest coverage?
Fulgent Genetics, Inc. (FLGT) reported interest coverage of -1,358× in Q1 2026.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.